Department of Vascular Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Phlebology. 2023 Oct;38(9):605-612. doi: 10.1177/02683555231200109. Epub 2023 Aug 31.
Compression therapy with the use of graduated compression stockings (GCSs) is a common treatment strategy for chronic venous disease (CVD). However, there is no uniform and objective standard to assess adherence to the use of GCSs. The aim of this study is to develop and validate a GCS Compliance Scale (GCSAS) to fill gaps in internationally recognized comprehensive scales and provide a useful tool for future research.
The items included in the GCSAS were based on a review of the literature and open-ended interviews with experts, who screened the initial items using an item-level content validity index. Then, pilot tests were conducted three times with 50 participants. After exclusion of redundant and cross-loading items by exploratory factor analysis, 290 subjects were recruited to evaluate the reliability and validity of the proposed GCSAS. Analyses included internal consistency, test-retest reliability, split-half reliability, construct validity, criterion validity, convergent validity, and discriminant validity.
The final GCSAS consisted of 17 items and 5 dimensions. The results of the exploratory factor analysis indicated that the variances of each factor explained were 22.03%, 14.85%, 14.74%, 14.16%, and 13.35%, and all 5 factors explained 79.13% of the variance among the 17 items. The factor loadings of all items were >0.7. Confirmatory factor analysis indicated that the indices were adequate. A significant positive correlation was found between the GCSAS and the Venous Insufficiency Epidemiological and Economic Study - Quality of Life questionnaire scores (r = 0.76, < 0.001). The Cronbach's alpha coefficient was 0.90, test-retest reliability was 0.81, and split-half reliability was 0.92.
The GCSAS showed good validity and reliability to assess compliance with the use of GCSs among patients with CVD.
使用梯度压力弹力袜(GCS)进行压缩治疗是慢性静脉疾病(CVD)的常用治疗策略。然而,目前尚无评估 GCS 使用依从性的统一和客观标准。本研究旨在开发和验证 GCS 依从性量表(GCSAS),以填补国际公认的综合量表中的空白,并为未来的研究提供有用的工具。
GCSAS 中的项目基于文献回顾和对专家的开放式访谈,这些专家使用项目级内容有效性指数筛选初始项目。然后,对 50 名参与者进行了三次试点测试。通过探索性因子分析排除冗余和交叉加载项目后,招募了 290 名受试者来评估拟议的 GCSAS 的可靠性和有效性。分析包括内部一致性、重测信度、分半信度、结构有效性、标准有效性、收敛有效性和判别有效性。
最终的 GCSAS 由 17 个项目和 5 个维度组成。探索性因子分析的结果表明,每个因子的方差解释率分别为 22.03%、14.85%、14.74%、14.16%和 13.35%,所有 5 个因子解释了 17 个项目之间 79.13%的方差。所有项目的因子负荷均>0.7。验证性因子分析表明指标是充分的。GCSAS 与静脉功能不全流行病学和经济研究-生活质量问卷评分之间存在显著正相关(r=0.76,<0.001)。Cronbach's alpha 系数为 0.90,重测信度为 0.81,分半信度为 0.92。
GCSAS 显示出良好的有效性和可靠性,可用于评估 CVD 患者对 GCS 使用的依从性。